ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,387Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 302

$518K Total Retail Price of All Prescriptions

Rank: 15 out of 302

350 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 350 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

12% of this provider’s 350 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 6,903 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $100 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
LEVOTHYROXINE SODIUM 424 333 1 9
FUROSEMIDE 313 278 2 4
SIMVASTATIN 267 247 3 3
OMEPRAZOLE 265 210 4 7
LISINOPRIL 233 171 5 1
DONEPEZIL HCL 153 153 6 27
MIRTAZAPINE 139 120 7 38
AMLODIPINE BESYLATE 130 125 8 2
RISPERIDONE 122 94 9 40
WARFARIN SODIUM 122 99 9 8
DIGOXIN 114 114 11 57
GABAPENTIN 112 85 12 18
POTASSIUM CHLORIDE 112 106 12 55
METOPROLOL SUCCINATE 109 102 14 6
KLOR-CON M20 101 74 15 107
POLYETHYLENE GLYCOL 3350 99 56 16 102
METOPROLOL TARTRATE 97 85 17 5
GLIPIZIDE 97 55 17 114
LEVOFLOXACIN 97 81 17 184
IPRATROPIUM-ALBUTEROL 94 55 20 179
CEPHALEXIN 91 75 21 123
CIPROFLOXACIN HCL 84 76 22 58
HYDROCHLOROTHIAZIDE 81 63 23 12
TRAZODONE HCL 81 69 23 36
ATORVASTATIN CALCIUM 78 53 25 10
TRAMADOL HCL 78 74 25 16
METFORMIN HCL 72 40 27 13
CARBIDOPA-LEVODOPA 71 56 28 35
DIVALPROEX SODIUM 70 45 29 64
ACETAMINOPHEN-CODEINE 68 68 S3 30 133
NAMENDA 68 55 30 67
CITALOPRAM HBR 67 65 32 30
LOSARTAN POTASSIUM 67 62 32 24
CARVEDILOL 63 54 34 19
NOVOLOG MIX 70-30 61 61 35 257
QUETIAPINE FUMARATE 59 35 36 54
CLOPIDOGREL 58 50 37 23
NEXIUM 56 38 38 47
NOVOLOG MIX 70-30 FLEXPEN 55 44 39 269
SERTRALINE HCL 52 44 40 43
PANTOPRAZOLE SODIUM 51 36 41 25
SYNTHROID 51 49 41 45
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 12, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.